Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...
This report offers insights into recent health news, encompassing advancements in Parkinson's and cancer treatments, ...
Kim Benda, who sought to challenge incumbent Mayor Mike Parkinson, was removed from the ballot on Monday morning after her petition papers were found to be unbound — a technical violation that ...
Kim Benda, who sought to challenge incumbent Mayor Mike Parkinson, was removed from the ballot on Monday morning after her petition papers were found to be unbound — a technical violation that ...
Dr. Cudkowicz is the Chair of Neurology at MGH, Director of the Sean M. Healey & AMG Center for ALS, and is the Julieanne Dorn Professor of Neurology at Harvard Medical School. A member of the ...
AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson's disease on Monday and said it's on track to seek approval for the drug from the Food and Drug ...
AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...
AbbVie reports Phase 3 TEMPO-2 trial success for tavapadon, a once-daily Parkinson's treatment, showing significant symptom ...
The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.
Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.
Stephen Knight, whose nonprofit saves lives by providing foster care for dogs while their owners focus on addiction recovery, ...
A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...